Impact of Chronic Obstructive Pulmonary Disease on Incidence, Microbiology and Outcome of Ventilator-Associated Lower Respiratory Tract Infections

Overview

Journal Microorganisms

Specialty Microbiology

Date 2020 Jan 26

PMID 31979375

Citations 5

Authors

Anahita Rouze

Pauline Boddaert

Ignacio Martin-Loeches

Pedro Povoa

Alejandro Rodriguez

Nassima Ramdane

Jorge Salluh

Marion Houard

Saad Nseir

Affiliations

Soon will be listed here.

Abstract

Objectives: To determine the impact of chronic obstructive pulmonary disease (COPD) on incidence, microbiology, and outcomes of ventilator-associated lower respiratory tract infections (VA-LRTI).

Methods: Planned ancillary analysis of TAVeM study, including 2960 consecutive adult patients who received invasive mechanical ventilation (MV) > 48 h. COPD patients (n = 494) were compared to non-COPD patients (n = 2466). The diagnosis of ventilator-associated tracheobronchitis (VAT) and ventilator-associated pneumonia (VAP) was based on clinical, radiological and quantitative microbiological criteria.

Results: No significant difference was found in VAP (12% versus 13%, p = 0.931), or VAT incidence (13% versus 10%, p = 0.093) between COPD and non-COPD patients. Among patients with VA-LRTI, Escherichia coli and Stenotrophomonas maltophilia were significantly more frequent in COPD patients as compared with non-COPD patients. However, COPD had no significant impact on multidrug-resistant bacteria incidence. Appropriate antibiotic treatment was not significantly associated with progression from VAT to VAP among COPD patients who developed VAT, unlike non-COPD patients. Among COPD patients, patients who developed VAT or VAP had significantly longer MV duration (17 days (9-30) or 15 (8-27) versus 7 (4-12), p < 0.001) and intensive care unit (ICU) length of stay (24 (17-39) or 21 (14-40) versus 12 (8-19), p < 0.001) than patients without VA-LRTI. ICU mortality was also higher in COPD patients who developed VAP (44%), but not VAT(38%), as compared to no VA-LRTI (26%, p = 0.006). These worse outcomes associated with VA-LRTI were similar among non-COPD patients.

Conclusions: COPD had no significant impact on incidence or outcomes of patients who developed VAP or VAT.

Citing Articles

Factors Associated With Multi-Drug Resistant Organisms Among Bronchiectasis Patients: A Retrospective Study of Bronchiectasis Patients in Jordan.

Al Oweidat K, Toubasi A, Khraisat F, Al-Sayegh T, Al-Harasis L, Albtoosh A Int J Gen Med. 2025; 18:391-402.

PMID: 39881954 PMC: 11776428. DOI: 10.2147/IJGM.S490196.

Lower Respiratory Tract Pathogens and Their Antimicrobial Susceptibility Pattern: A 5-Year Study.

Santella B, Serretiello E, De Filippis A, Veronica F, Iervolino D, DellAnnunziata F Antibiotics (Basel). 2021; 10(7).

PMID: 34356772 PMC: 8300710. DOI: 10.3390/antibiotics10070851.

Is COPD associated with increased risk for microaspiration in intubated critically ill patients?.

Degroote T, Jaillette E, Reignier J, Zerimech F, Girault C, Brunin G Ann Intensive Care. 2021; 11(1):7.

PMID: 33428002 PMC: 7798009. DOI: 10.1186/s13613-020-00794-1.

Effect of chronic obstructive pulmonary disease combined with ventilator-associated pneumonia on patient outcomes: A systematic review and meta-analysis.

Yin M, Liu M Exp Ther Med. 2020; 20(6):273.

PMID: 33199998 PMC: 7664610. DOI: 10.3892/etm.2020.9403.

Editorial for Special Issue "Multidrug-Resistant Pathogens".

Koulenti D, Fragkou P, Tsiodras S Microorganisms. 2020; 8(9).

PMID: 32927625 PMC: 7563160. DOI: 10.3390/microorganisms8091383.

References

Melsen W, Rovers M, Groenwold R, Bergmans D, Camus C, Bauer T . Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies. Lancet Infect Dis. 2013; 13(8):665-71. DOI: 10.1016/S1473-3099(13)70081-1. View

Nair G, Niederman M . Ventilator-associated pneumonia: present understanding and ongoing debates. Intensive Care Med. 2014; 41(1):34-48. PMC: 7095124. DOI: 10.1007/s00134-014-3564-5. View

Esteban A, Frutos-Vivar F, Muriel A, Ferguson N, Penuelas O, Abraira V . Evolution of mortality over time in patients receiving mechanical ventilation. Am J Respir Crit Care Med. 2013; 188(2):220-30. DOI: 10.1164/rccm.201212-2169OC. View

Nseir S, Di Pompeo C, Cavestri B, Jozefowicz E, Nyunga M, Soubrier S . Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome. Crit Care Med. 2006; 34(12):2959-66. DOI: 10.1097/01.CCM.0000245666.28867.C6. View

Rouze A, Cottereau A, Nseir S . Chronic obstructive pulmonary disease and the risk for ventilator-associated pneumonia. Curr Opin Crit Care. 2014; 20(5):525-31. DOI: 10.1097/MCC.0000000000000123. View

Bouhemad B, Dransart-Raye O, Mojoli F, Mongodi S . Lung ultrasound for diagnosis and monitoring of ventilator-associated pneumonia. Ann Transl Med. 2018; 6(21):418. PMC: 6275403. DOI: 10.21037/atm.2018.10.46. View

Parmentier-Decrucq E, Poissy J, Favory R, Nseir S, Onimus T, Guerry M . Adverse events during intrahospital transport of critically ill patients: incidence and risk factors. Ann Intensive Care. 2013; 3(1):10. PMC: 3639083. DOI: 10.1186/2110-5820-3-10. View

Koulenti D, Blot S, Dulhunty J, Papazian L, Martin-Loeches I, Dimopoulos G . COPD patients with ventilator-associated pneumonia: implications for management. Eur J Clin Microbiol Infect Dis. 2015; 34(12):2403-11. DOI: 10.1007/s10096-015-2495-6. View

Bouza E, Perez Granda M, Hortal J, Barrio J, Cercenado E, Munoz P . Pre-emptive broad-spectrum treatment for ventilator-associated pneumonia in high-risk patients. Intensive Care Med. 2013; 39(9):1547-55. DOI: 10.1007/s00134-013-2997-6. View

10.

Martin-Loeches I, Povoa P, Rodriguez A, Curcio D, Suarez D, Mira J . Incidence and prognosis of ventilator-associated tracheobronchitis (TAVeM): a multicentre, prospective, observational study. Lancet Respir Med. 2015; 3(11):859-68. DOI: 10.1016/S2213-2600(15)00326-4. View

11.

Paul M, Shani V, Muchtar E, Kariv G, Robenshtok E, Leibovici L . Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother. 2010; 54(11):4851-63. PMC: 2976147. DOI: 10.1128/AAC.00627-10. View

12.

Craven D, Lei Y, Ruthazer R, Sarwar A, Hudcova J . Incidence and outcomes of ventilator-associated tracheobronchitis and pneumonia. Am J Med. 2013; 126(6):542-9. DOI: 10.1016/j.amjmed.2012.12.012. View

13.

Karvouniaris M, Makris D, Manoulakas E, Zygoulis P, Mantzarlis K, Triantaris A . Ventilator-associated tracheobronchitis increases the length of intensive care unit stay. Infect Control Hosp Epidemiol. 2013; 34(8):800-8. DOI: 10.1086/671274. View

14.

Nseir S, Di Pompeo C, Brisson H, Dewavrin F, Tissier S, Diarra M . Intensive care unit-acquired Stenotrophomonas maltophilia: incidence, risk factors, and outcome. Crit Care. 2006; 10(5):R143. PMC: 1751051. DOI: 10.1186/cc5063. View

15.

Vestbo J, Hurd S, Agusti A, Jones P, Vogelmeier C, Anzueto A . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2012; 187(4):347-65. DOI: 10.1164/rccm.201204-0596PP. View

16.

Bekaert M, Timsit J, Vansteelandt S, Depuydt P, Vesin A, Garrouste-Orgeas M . Attributable mortality of ventilator-associated pneumonia: a reappraisal using causal analysis. Am J Respir Crit Care Med. 2011; 184(10):1133-9. DOI: 10.1164/rccm.201105-0867OC. View

17.

Magiorakos A, Srinivasan A, Carey R, Carmeli Y, Falagas M, Giske C . Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2011; 18(3):268-81. DOI: 10.1111/j.1469-0691.2011.03570.x. View

18.

Torres A, Aznar R, Gatell J, Jimenez P, Gonzalez J, Ferrer A . Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis. 1990; 142(3):523-8. DOI: 10.1164/ajrccm/142.3.523. View

19.

Rodriguez A, Povoa P, Nseir S, Salluh J, Curcio D, Martin-Loeches I . Incidence and diagnosis of ventilator-associated tracheobronchitis in the intensive care unit: an international online survey. Crit Care. 2014; 18(1):R32. PMC: 4057509. DOI: 10.1186/cc13725. View

20.

Upchurch C, Grijalva C, Wunderink R, Williams D, Waterer G, Anderson E . Community-Acquired Pneumonia Visualized on CT Scans but Not Chest Radiographs: Pathogens, Severity, and Clinical Outcomes. Chest. 2017; 153(3):601-610. PMC: 5989638. DOI: 10.1016/j.chest.2017.07.035. View